Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets
Tacrolimus-induced diabetes in rats courses with suppressed insulin gene expression in pancreatic islets
复制标题
DOI:
10.1111/j.1600-6143.2007.01946.x
复制
发表时间:
2007-11-01
影响因子:
8.8
通讯作者:
Tamarit-Rodriguez, J.
中科院分区:
文献类型:
--
作者:
Hernandez-Fisac, I.;Pizarro-Delgado, J.;Tamarit-Rodriguez, J.
An animal model of post-transplant diabetes was induced in rats by treating them daily with 0.1 mg/kg body weight of tacrolimus (FK506) in two i.p. injections. Rats developed hyperglycaemia and glucose intolerance after 9 days of treatment. Pancreatic islets, isolated from treated rats on different days, showed a decreased capacity to secrete insulin in response to 20 mM glucose at days 7 and 14. This suppression of insulin secretion was preceded by a reduction of the islet insulin content on day 5 that was progressively decreasing until the end of the treatment (day 14). Islet content of insulin mRNAs, transcribed from rat insulin genes 1 and 2, was strongly suppressed, similar to the insulin content, at days 7 and 14. Islet mass was not strikingly modified by tacrolimus treatment: the DNA content was slightly decreased at the end (day 14) and the rate of islet cell apoptosis slightly increased. Tacrolimus-induced diabetes in the rat seems to be mainly provoked by a decreased insulin gene transcription with little or no alteration of islet mass. This explains that the observed suppression of all the islet and animal parameters studied was completely reversed 2 weeks after interrupting tacrolimus treatment.